TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
Zhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi I...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTT |
id |
doaj-22b5adaaa63148a9aa1a413ce3d84650 |
---|---|
record_format |
Article |
spelling |
doaj-22b5adaaa63148a9aa1a413ce3d846502020-11-25T02:55:05ZengDove Medical PressOncoTargets and Therapy1178-69302020-09-01Volume 139587959757455TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer CellsZhou ZLiu XLi YLi JDeng WZhong JChen LLi YZeng XWang GZhu JFu BZhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi Institute of Urology, Nanchang, People’s Republic of China; 3Department of Urology, Third Hospital of Hangzhou, Hangzhou, People’s Republic of China; 4Department of Surgery, Nankang District Chinese Medicine Hospital, Ganzhou, People’s Republic of China; 5Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin FuDepartment of Urology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86 13879103861Email urofubin@sina.comJingyu ZhuDepartment of Urology, Third Hospital of Hangzhou, 38 Westlake Road, Hangzhou, Zhejiang 310009, People’s Republic of ChinaTel +86 571 87827269Email zhujingyu@126.comBackground: The tumor protein p53-inducible nuclear protein 2 (TP53INP2), an autophagy protein, is essential for autophagosome formation. The deregulation of autophagy is associated with multiple human diseases, including cancer. The present study aims to explore the role of TP53INP2 in bladder cancer.Materials and Methods: Quantitative real-time polymerase chain reaction was used to detect the mRNA level. Relative TP53INP2 protein expression was detected by immunohistochemistry and Western blot. The effect of TP53INP2 silencing on the proliferation, migration, and invasion of bladder cancer cells was investigated by CCK-8 detection kit and transwell assay. In addition, transfection and immunofluorescence were performed.Results: In this study, we report that high expression of TP53INP2 is correlated with poor patient survival in bladder cancer. Results demonstrate that the depletion of TP53INP2 inhibits the migration, invasion, and epithelial-to-mesenchymal transition (EMT) of bladder cancer cells. The underlying mechanism was explored. Results show that the TP53INP2 knockdown suppresses EMT by inhibiting the active non-phosphorylated β-catenin and decreasing the Snail1 levels. Furthermore, the glycogen synthase kinase-3 beta (GSK-3β) inhibitor IM-12 abrogates the effect of TP53INP2 silencing. Interestingly, the induction of autophagy partially abrogates the TP53INP2 knockdown-induced decrease in active β-catenin and inhibition of migration and invasion in bladder cancer cells.Conclusion: In summary, our results show that the downregulation of TP53INP2 inhibits EMT via the GSK-3β/β-catenin/Snail1 pathway in bladder cancer. The findings of this study uncover the novel role of TP53INP2 and offer new insights into bladder cancer clinical therapy.Keywords: TP53INP2, β-catenin, Snail1, EMT, bladder cancerhttps://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTTtp53inp2β-cateninsnail1emtbladder cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhou Z Liu X Li Y Li J Deng W Zhong J Chen L Li Y Zeng X Wang G Zhu J Fu B |
spellingShingle |
Zhou Z Liu X Li Y Li J Deng W Zhong J Chen L Li Y Zeng X Wang G Zhu J Fu B TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells OncoTargets and Therapy tp53inp2 β-catenin snail1 emt bladder cancer |
author_facet |
Zhou Z Liu X Li Y Li J Deng W Zhong J Chen L Li Y Zeng X Wang G Zhu J Fu B |
author_sort |
Zhou Z |
title |
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells |
title_short |
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells |
title_full |
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells |
title_fullStr |
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells |
title_full_unstemmed |
TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells |
title_sort |
tp53inp2 modulates epithelial-to-mesenchymal transition via the gsk-3β/β-catenin/snail1 pathway in bladder cancer cells |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2020-09-01 |
description |
Zhengtao Zhou,1,2,* Xiaoqiang Liu,1,2,* Yulei Li,1 Junhua Li,3 Wen Deng,1 Jian Zhong,4 Luyao Chen,1 Yu Li,1 Xiantao Zeng,5 Gongxian Wang,1,2 Jingyu Zhu,3 Bin Fu1,2 1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Jiangxi Institute of Urology, Nanchang, People’s Republic of China; 3Department of Urology, Third Hospital of Hangzhou, Hangzhou, People’s Republic of China; 4Department of Surgery, Nankang District Chinese Medicine Hospital, Ganzhou, People’s Republic of China; 5Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin FuDepartment of Urology, The First Affiliated Hospital of Nanchang University, 17 Yongwaizheng Street, Nanchang, Jiangxi 330006, People’s Republic of ChinaTel +86 13879103861Email urofubin@sina.comJingyu ZhuDepartment of Urology, Third Hospital of Hangzhou, 38 Westlake Road, Hangzhou, Zhejiang 310009, People’s Republic of ChinaTel +86 571 87827269Email zhujingyu@126.comBackground: The tumor protein p53-inducible nuclear protein 2 (TP53INP2), an autophagy protein, is essential for autophagosome formation. The deregulation of autophagy is associated with multiple human diseases, including cancer. The present study aims to explore the role of TP53INP2 in bladder cancer.Materials and Methods: Quantitative real-time polymerase chain reaction was used to detect the mRNA level. Relative TP53INP2 protein expression was detected by immunohistochemistry and Western blot. The effect of TP53INP2 silencing on the proliferation, migration, and invasion of bladder cancer cells was investigated by CCK-8 detection kit and transwell assay. In addition, transfection and immunofluorescence were performed.Results: In this study, we report that high expression of TP53INP2 is correlated with poor patient survival in bladder cancer. Results demonstrate that the depletion of TP53INP2 inhibits the migration, invasion, and epithelial-to-mesenchymal transition (EMT) of bladder cancer cells. The underlying mechanism was explored. Results show that the TP53INP2 knockdown suppresses EMT by inhibiting the active non-phosphorylated β-catenin and decreasing the Snail1 levels. Furthermore, the glycogen synthase kinase-3 beta (GSK-3β) inhibitor IM-12 abrogates the effect of TP53INP2 silencing. Interestingly, the induction of autophagy partially abrogates the TP53INP2 knockdown-induced decrease in active β-catenin and inhibition of migration and invasion in bladder cancer cells.Conclusion: In summary, our results show that the downregulation of TP53INP2 inhibits EMT via the GSK-3β/β-catenin/Snail1 pathway in bladder cancer. The findings of this study uncover the novel role of TP53INP2 and offer new insights into bladder cancer clinical therapy.Keywords: TP53INP2, β-catenin, Snail1, EMT, bladder cancer |
topic |
tp53inp2 β-catenin snail1 emt bladder cancer |
url |
https://www.dovepress.com/tp53inp2-modulates-epithelial-to-mesenchymal-transition-via-the-gsk-3b-peer-reviewed-article-OTT |
work_keys_str_mv |
AT zhouz tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT liux tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT liy tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT lij tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT dengw tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT zhongj tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT chenl tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT liy tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT zengx tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT wangg tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT zhuj tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells AT fub tp53inp2modulatesepithelialtomesenchymaltransitionviathegsk3betabetacateninsnail1pathwayinbladdercancercells |
_version_ |
1724718408123023360 |